Nicotinell Spearmint (Nicotine Polacrilex)

• Nicotinell Spearmint is a nicotine replacement therapy used in smoking cessation.
• Smoking cessation: assists adult smokers in reducing withdrawal symptoms and cravings during quit attempts.
• Tobacco dependence: supports gradual reduction of nicotine intake for individuals dependent on tobacco.
• Relapse prevention: helps maintain abstinence after an initial quit attempt by providing controlled nicotine exposure.

• Nicotine Polacrilex is a polymer-bound nicotine complex that releases nicotine slowly when placed against the buccal mucosa. The nicotine is absorbed through the oral mucosa into the bloodstream, where it binds to nicotinic acetylcholine receptors in the central nervous system, partially stimulating the same pathways activated by cigarette smoking and thereby diminishing withdrawal and craving sensations.

Nicotinell Spearmint may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Mouth irritation or soreness
• Throat irritation or dryness
• Nausea or mild gastrointestinal discomfort
• Increased salivation or hiccups

Serious or Rare Side Effects

• Allergic reactions such as rash, swelling, or itching
• Dizziness or light‑headedness
• Chest pain or palpitations
• Severe mouth ulceration or anaphylaxis

• When using Nicotinell Spearmint, consider the following safety measures.
• Cardiovascular assessment: evaluate patients with known heart disease before initiating therapy.
• Medical supervision: use under the guidance of a healthcare professional, especially for first‑time quitters.
• Non‑smokers: the product is not intended for individuals who do not currently use tobacco.
• Concurrent nicotine products: avoid using other nicotine replacement therapies simultaneously to prevent overdose.
• Pregnancy and lactation: safety has not been established; consult a physician before use.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotinell Spearmint can interact with other substances that affect nicotine levels or cardiovascular function.

Major Interactions (Avoid)

• Concurrent use of other nicotine replacement products: risk of nicotine toxicity.
• Use with monoamine oxidase inhibitors (MAOIs): potential for hypertensive reactions.

Moderate Interactions (Monitor Closely)

• CYP2A6 inhibitors (e.g., certain antifungals): may increase nicotine plasma concentrations.
• Beta‑blockers: nicotine‑induced tachycardia may be masked.
• Certain antidepressants (e.g., SSRIs): may alter nicotine metabolism and affect efficacy.